A mix of two compounds: Drostanolone propionate, first described in 1959, is a DHT-based steroid recognized for its moderate anabolic properties and strong anti-estrogenic effects. It serves in lean muscle retention and fat loss during the cutting phases. Developed for breast cancer treatment, it's marketed under names like "Masteron" and "Drolban," prized for minimal edema. Drostanolone Enanthate is famous for improving tissue strength without significant weight gain, making it a popular choice for athletes aiming for athletic builds.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about PHARMA MIX M 300 by Pharmacom Labs, consult with your doctor or healthcare professional.
Choudhary, M. I., Siddiqui, M., Yousuf, S., (2017). Bio-catalytic structural transformation of anti-cancer steroid, drostanolone enanthate with Cephalosporium aphidicola and Fusarium lini, and cytotoxic potential evaluation of its metabolites against certain cancer cell lines. Frontiers in Pharmacology.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Home
